Sun Pharma Advanced Research Company has informed that the Board of Directors of the Company at their meeting held from 12:00 Noon to 02:00 pm today, took on record and duly approved the Un-audited financial results of the Company for the quarter and nine months ended 31st December 2017 which is enclosed herewith along with the Limited Review Report of the Statutory Auditors thereon as Annexure I.
The above information is a part of company’s filings submitted to BSE.